Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study

HIGHLIGHTS

• who: Tofacitinib, and Clopper-u00ad, from the Contributors All people who contributed to this work are listed as coauthors or collaboratorsFunding The study was sponsored by the National Natural Science Foundation Youth Project (71804109) and Rising Stars of Medical Talents-u00adYouth Development Program (SHWSRS(2021)_099). Competing interests None declared. Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research. Patient consent for publication Obtained. Ethics approval This study involves human participants and was approved by Shanghai Jiao Tong University, School of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.